Skills over pills? A clinical gastroenterologist's primer in cognitive behavioral therapy for irritable bowel syndrome

Irritable bowel syndrome is a common, painful, and often disabling GI disorder for which there is no satisfactory medical or dietary treatment. The past 10 years have seen the development and validation of a number of psychological treatments of which CBT is arguably the most effective based on two...

Celý popis

Uloženo v:
Podrobná bibliografie
Vydáno v:Expert review of gastroenterology & hepatology Ročník 14; číslo 7; s. 601 - 618
Hlavní autor: Lackner, Jeffrey M.
Médium: Journal Article
Jazyk:angličtina
Vydáno: England Taylor & Francis 02.07.2020
Témata:
behavioral intervention
chronic pain
Cognitive Behavioral Therapy
digital therapeutics
FDA
Humans
IBS treatment
Irritable Bowel Syndrome - drug therapy
Irritable Bowel Syndrome - physiopathology
Irritable Bowel Syndrome - psychology
Irritable Bowel Syndrome - therapy
psychotherapy
Stress, Psychological - physiopathology
Stress, Psychological - therapy
Treatment Outcome
cognitive behavioral therapy
digital therapeutics
FDA
chronic pain
IBS treatment
behavioral intervention
psychotherapy
ISSN:1747-4124, 1747-4132, 1747-4132
On-line přístup:Získat plný text
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo vytvoří štítek k tomuto záznamu!
Popis
Shrnutí:Irritable bowel syndrome is a common, painful, and often disabling GI disorder for which there is no satisfactory medical or dietary treatment. The past 10 years have seen the development and validation of a number of psychological treatments of which CBT is arguably the most effective based on two recently conducted multiple site trials from two investigative teams in the UK and USA. The purpose of this review is to describe the principles, processes, procedures, and empirical basis supporting CBT and distinguish it from other psychological treatments available to clinical GE whose patients suffer from refractory IBS. The efficacy of CBT in treating refractory IBS patients is well established but there is limited understanding of why it works and for whom it is most beneficial. Further, its availability is generally limited to tertiary care settings which may undermine its value proposition if improved self-management is not accompanied by other health-care efficiencies. Systematic efforts to increase both the efficiency of CBT and the way it is delivered (e.g. digital therapeutics, integration into primary care) is critical to optimizing CBT's potential and reducing the public health burden IBS imposes.
Bibliografie:ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
ObjectType-Review-3
content type line 23
ISSN:1747-4124
1747-4132
1747-4132
DOI:10.1080/17474124.2020.1780118